Rhonda Farnum
Technik-/Wissenschafts-/F&E-Leiter bei THERAVANCE BIOPHARMA, INC.
Vermögen: 3 Mio $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Dean Mitchell | M | 68 | 10 Jahre | |
Eran Broshy | M | 65 | 10 Jahre | |
Deepa Pakianathan | M | 59 | 4 Jahre | |
Susannah Gray | F | 63 | 1 Jahre | |
Rick Winningham | M | 64 | 11 Jahre | |
Jim Kelly | M | 43 | 1 Jahre | |
Donal O'Connor | M | 73 | 9 Jahre | |
Laurie Alsup | M | 70 | 6 Jahre | |
Jeremy Grant | M | 36 | 1 Jahre | |
Richard Graham | M | - | - | |
Brett Grimaud | M | 50 | 3 Jahre | |
Aziz Sawaf | M | 42 | 10 Jahre | |
Aine Miller | M | 47 | - | |
Stacy Pryce | F | - | - | |
Stuart Knight | M | - | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
Susan Molineaux | M | 70 | 7 Jahre | |
Gail B. Cohen | F | - | 2 Jahre | |
Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
Renée Galá | F | 52 | 5 Jahre | |
Brett K. Haumann | M | 54 | 7 Jahre | |
Asif Ali | M | 50 | 4 Jahre | |
Robert Gunderson | M | 72 | 8 Jahre | |
Peter S. Ringrose | M | 78 | 7 Jahre | |
George M. Whitesides | M | 84 | 8 Jahre | |
Bradford J. Shafer | M | 63 | 7 Jahre | |
William Young | M | 79 | 10 Jahre | |
Burt Malkiel | M | 90 | 11 Jahre | |
Sujay Kango | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
Kanya Rajangam | M | 50 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
Alexander Dobbin | M | - | 3 Jahre | |
Shehnaaz Suliman | M | 52 | 2 Jahre | |
Barbara Klencke | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
Vijay Sabesan | M | 51 | 7 Jahre | |
Andrew Hindman | M | 51 | 3 Jahre | |
Rosh Dias | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 Jahre |
Francesco Galimi | M | 56 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 Jahre |
Jeff Knight | M | 52 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 Jahre |
Jane Chung | F | 53 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
Dana Pizzuti | M | 68 | - | |
Bill Tan | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 Jahre |
Robert Goeltz | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 42 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Rhonda Farnum
- Persönliches Netzwerk